Citadel, Virtu, Susquehanna Fight Biotech Company Lawsuit
Citadel and 7 other market makers have jointly filed motion to dismiss the lawsuit issued by cancer research company Northwest Therapeutics.
NWBO Stock: Citadel Chooses to Profit from Cancer Drug Company
Citadel Securities has chosen to profit from shorting NWBO stock. Now more and more companies are getting together to fight manipulation.